Document Detail


Hepatitis C-associated hepatocellular carcinoma.
MedLine Citation:
PMID:  2169456     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In the United States, a large percentage of patients with hepatocellular carcinoma are serologically negative for hepatitis B. We conducted a retrospective study to determine the prevalence of hepatitis C antibody in the sera of 59 patients with hepatocellular carcinoma who were HBsAg-negative and had no evidence of alcoholic liver disease, primary biliary cirrhosis, autoimmune hepatitis, hemochromatosis or alpha 1-antitrypsin deficiency. Twenty patients (34%) were hepatitis C antibody-positive and hepatitis B core antibody-negative. All twenty patients had underlying cirrhosis, and seven (35%) had histories of transfusions. Eleven (19%) additional patients were also hepatitis C antibody-positive but were hepatitis B core antibody-positive as well. Twenty-one (36%) patients were both hepatitis C antibody- and hepatitis B core antibody-negative and seven (12%) were hepatitis C antibody-negative but hepatitis B core antibody-positive. The prevalence of hepatitis C antibody was also determined among three other population groups serving as controls and found to be 14% in 28 HbsAg-positive patients with hepatocellular carcinoma, 44% in 76 patients with cryptogenic cirrhosis and 0.5% in 200 consecutive volunteer blood donors. We conclude that hepatitis C antibody is prevalent among patients with hepatocellular carcinoma and may therefore be a common causative agent of this disease. A significant number of patients with and without cirrhosis, negative for hepatitis C antibody and hepatitis B core antibody, remain without a discernible cause for this malignancy. Perhaps a second- or third-generation test will detect hepatitis C antibody in some of these patients.
Authors:
F Hasan; L J Jeffers; M De Medina; K R Reddy; T Parker; E R Schiff; M Houghton; Q L Choo; G Kuo
Related Documents :
12883486 - Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis c.
8514896 - Ultrasonographic changes of early liver cirrhosis in chronic hepatitis b: a longitudina...
19863496 - Systematic review: portal vein thrombosis in cirrhosis.
11276276 - Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-re...
7889946 - Respiratory infection with chlamydia pneumoniae in middle-aged and older adult outpatie...
11074466 - Impaired humoral responses to subgenus d adenovirusenovirus infections in hiv-positive ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Hepatology (Baltimore, Md.)     Volume:  12     ISSN:  0270-9139     ISO Abbreviation:  Hepatology     Publication Date:  1990 Sep 
Date Detail:
Created Date:  1990-10-24     Completed Date:  1990-10-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8302946     Medline TA:  Hepatology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  589-91     Citation Subset:  IM    
Affiliation:
Division of Hepatology, University of Miami School of Medicine.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carcinoma, Hepatocellular / epidemiology,  etiology*,  immunology
Florida / epidemiology
Hepatitis Antibodies / blood
Hepatitis B Antibodies / blood
Hepatitis B Core Antigens / immunology
Hepatitis B Surface Antigens / blood
Hepatitis C / complications*,  epidemiology,  immunology
Hepatitis Viruses / immunology
Hepatitis, Viral, Human / complications*
Humans
Liver Neoplasms / epidemiology,  etiology*,  immunology
Prevalence
Retrospective Studies
Seroepidemiologic Studies
Chemical
Reg. No./Substance:
0/Hepatitis Antibodies; 0/Hepatitis B Antibodies; 0/Hepatitis B Core Antigens; 0/Hepatitis B Surface Antigens
Comments/Corrections
Comment In:
Hepatology. 1991 Nov;14(5):959   [PMID:  1657757 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hepatitis B virus replication in Chinese patients with hepatocellular carcinoma.
Next Document:  Estimating clozapine's cost to the nation.